Efficacy of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer: Analysis of Three Phase-II Trials-Reference-Cited by-同舟云学术

Efficacy of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer: Analysis of Three Phase-II Trials

Published:2021-11-25 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Cancanelli Luca,Rivano Melania,Di Spazio Lorenzo,Chiumente Marco,Mengato Daniele,Messori Andrea

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference25 articles.

1. The Global Cancer Observatory. (2021). Accessed. August 30, 2021: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf.

2. Microsatellite instability in colorectal cancer;Boland CR;Gastroenterology,2010

3. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis;Ionov Y;Nature,1993

4. The chromosomal instability pathway in colon cancer;Pino MS;Gastroenterology,2010

5. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies;Venderbosch S;Clin Cancer Res,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of immune‐related hub genes and construction of an immune‐related gene prognostic index for low‐grade glioma;Journal of Cellular and Molecular Medicine;2023-09-29

2. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer;Journal for ImmunoTherapy of Cancer;2023-06

3. Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments;Hematology Reports;2023-01-13

4. The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma;Cureus;2022-08-25

5. Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data;Cancer Medicine;2022-08-03